Details

Product Name in the RMS: Rivastigmin-ratiopharm 13,3 mg/24 Stunden transdermales Pflaster

MR Number: DE/H/3404/003
Date of outcome: 28.05.2015

Type of application
Level 1: Level 2: Level 3: Level 4: Level 5:	Line Extension Initial Application Generic Chemical Substance Prescription Only
Active Substances	rivastigmine 27 mg
Form	Transdermal patch
MA Holder in the RMS	ratiopharm GmbH Graf-Arco-Str. 3 89079 Ulm Germany
RMS	Germany
Date of last change	09.11.2021
ATC-Code	N06DA03 Rivastigmine

CMS Country	Domestic Product Name
Austria	Rivastigmin ratiopharm 13,3 mg/24 Stunden transdermales Pflaster
Netherlands
Portugal
Slovenia
Spain
XI

Documents
PAR:	DE_H_3404_003_PAR.pdf (25.07.2017)
FinalLabelling:	DE_H_3404_003_FinalLabelling_1of8.pdf (07.03.2018)
FinalLabelling:	DE_H_3404_003_FinalLabelling_2of8.pdf (07.03.2018)
FinalLabelling:	DE_H_3404_003_FinalLabelling_3of8.pdf (07.03.2018)
FinalLabelling:	DE_H_3404_003_FinalLabelling_4of8.pdf (07.03.2018)
FinalLabelling:	DE_H_3404_003_FinalLabelling_5of8.pdf (07.03.2018)
FinalLabelling:	DE_H_3404_003_FinalLabelling_6of8.pdf (07.03.2018)
FinalLabelling:	DE_H_3404_003_FinalLabelling_7of8.pdf (07.03.2018)
FinalLabelling:	DE_H_3404_003_FinalLabelling_8of8.pdf (07.03.2018)
Finalised Product Information:	DE_H_3404_003_FinalPI_1of2.pdf (03.11.2021)
Finalised Product Information:	DE_H_3404_003_FinalPI_2of2.pdf (03.11.2021)